BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cambridge Bioscience Partnership Ltd Announces Collaboration With NeurAxon


10/19/2005 5:12:18 PM

CAMBRIDGE, England, November 25 /PRNewswire/ -- Cambridge Bioscience Partnership Ltd today announced that it has entered into an agreement with NeurAxon. Under the terms of the agreement Cambridge Bioscience Partnership Ltd will provide assay development and screening services to NeurAxon for research on undisclosed targets.

Drs Bob Gordon and Ed Zanders, co-founders and Directors of Cambridge Bioscience Partnership Ltd, said: "We are delighted to be working with NeurAxon Inc. This agreement is precisely in line with our strategy of partnering our assay development and screening capabilities."

Dr John Andrews, President of NeurAxon Inc commented: "It is a pleasure to be collaborating with a company like Cambridge Bioscience Partnership Ltd that can be trusted to deliver a highly professional service."

Cambridge Bioscience Partnership Ltd

Based in Cambridge UK, the company draws on the expertise of a highly experienced team of industrial scientists to provide drug discovery consultancy and laboratory services. Current customers include Cytomyx Ltd and Purely Proteins Ltd.

NeurAxon Inc.

NeurAxon Inc. is developing new drugs for the treatment of pain and other CNS disorders. NeurAxon Inc. believes good science can make a difference in improving the quality of life for people suffering from chronic pain.

Web: http://www.cambp.com/

Web: http://www.nrxn.com/

Cambridge BioScience Partnership Ltd

CONTACT: Contact Details: Cambridge Bioscience Partnership Ltd, StJohn's Innovation Centre, Cowley Road, Cambridge CB4 0WS,United Kingdom, Tel: +44-(0)1223-208534, Fax:+44-(0)1223-207378, Email: info@cambp.com; NeurAxon Inc,16-1375 Southdown Road, Suite 318, Mississauga, Ontario, CanadaL5J 2Z1; Tel: +1-905-823-3110, Email: info@nrxn.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES